Investors

A lab technician marks a test tube in a lab
  • Creating value for our company, our shareholders and society

Investors

We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.

Novartis Investors Event Calendar

View recent presentations and learn more about upcoming events.

June 22, 2021
Iptacopan (LNP023) update

Learn More

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Enter the Information Center

Environmental, Social and Governance (ESG)

Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.

Learn More

We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.

Explore the ESG Indices

ESG Updates: Apr 28, 2021 (PDF 0.3 MB)Jan 27, 2021 (PDF 0.5 MB) | Oct 28, 2020 (PDF 0.5 MB)July 24, 2020 (PDF 0.6 MB)
Latest updates: Novartis Enterprise Risk Management (PDF 0.2 MB)  | Materiality Assessments Webinars

Share Price

  • SIX

    85.72CHF

    as of Jun 18, 17:31 CEST

    -0.21 (-0.24%)

  • NYSE

    93.01USD

    as of Jun 18, 16:00 EDT

    -1.14 (-1.21%)

View stock performance
Featured Publications and Recent News
Pulse Updates

Novartis receives FDA Breakthrough Therapy designation for investigational 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer (mCRPC)

Learn More

Novartis Clinical Pipeline

Our broad portfolio and strong pipeline help us offset the recurring impact of patent expirations for key products.

Explore Our Pipeline

Investor Relations Contacts

For questions about investor relations or the share registry, please contact our team.

Novartis AG
Lichtstrasse 35
CH-4056 Basel, Switzerland